The CDC and FDA have recommended a ban on the use of the Johnson & Johnson COVID-19 vaccine to investigate reports of potentially dangerous blood clots – a condition known as cerebral venous sinus thrombosis – after vaccination. In six days. . Out of which one woman died.
Over 6.8 million people in the United States have received Jammu and Kashmir vaccines, most with or without mild side effects. Out of these millions, six have experienced clots, Agencies said, Adding that “these events appear to be extremely rare.”
What is cerebral venous sinus thrombosis and what are the symptoms if you have recently received a Jammu and Kashmir tablet? And what should you do? Here’s what the FDA and CDC say:
J & J Vaccine – For Consumers
- Those who have received the Jammu and Kashmir vaccine, who are experiencing severe headaches, abdominal pain, leg pain, or shortness of breath within three weeks of vaccination, should contact their healthcare provider.
- If you have received a J&J shot and have not developed any side effects associated with signs of blood clots within three weeks of vaccination, then there is a possibility of risk of adverse reactions. Health officials have urged patients to continue monitoring symptoms.
J & J Vaccine – For Doctors
- Health care providers are asked to report adverse events in the vaccine adverse event reporting system https://vaers.hhs.gov/reportevent.html
- Ask anyone presenting with reported side effects if they have recently been vaccinated.
- The FDA and CDC offer this additional warning because of the “unique treatment” required for this type of clotting: “The treatment of this specific type of blood clot is different from the treatment that can usually be administered. Usually But, an anticoagulant drug called peperin. Is used for the treatment of blood clots. In this setting, administration of heparin can be dangerous, and alternative treatments need to be given. “
What is the cause of this clotting?
It is not yet known why rare blood clots are occurring in some patients who receive the Jammu and Kashmir vaccine. The FDA and CDC stated that the six people who experienced clots were all women between the ages of 18 and 48, with symptoms within six to 13 days. He had a cerebral venous sinus thrombosis or CVST, as well as low levels of blood platelets. New York Times Report One woman died and another woman is hospitalized in critical condition.
So far the concern about abnormal blood clots has centered on AstraZeneca’s vaccine, which has not yet received authorization in the US last week, with European regulators saying they found a possible link between shots and a very rare type of blood that Happens together. With less blood platelets, it seems to occur more in young people.
J & J and AstraZeneca vaccines are made with the same technology. Unlike the Pfizer and Modern Vaccines, which train the body to recognize the spike protein that coats the outer surface of the coronavirus, the vaccines of J and K and AstraZeneca carry a spike gene in the body called a cold virus called choline. Let’s use. J and J use a human adenovirus to make their vaccine while AstraZeneca uses a chimpanzee variant.